Roth Ch Acquisition V Co. (NASDAQ:ROCLU – Get Rating) was the recipient of a significant growth in short interest in the month of August. As of August 31st, there was short interest totalling 400 shares, a growth of 100.0% from the August 15th total of 200 shares. Based on an average daily volume of 19,000 shares, the short-interest ratio is presently 0.0 days.
Roth Ch Acquisition V Stock Performance
ROCLU stock opened at $10.04 on Friday. The firm has a fifty day moving average price of $9.98 and a two-hundred day moving average price of $9.97. Roth Ch Acquisition V has a 1-year low of $9.67 and a 1-year high of $10.27.
Get Roth Ch Acquisition V alerts:Institutional Trading of Roth Ch Acquisition V
A number of hedge funds and other institutional investors have recently made changes to their positions in ROCLU. Walleye Capital LLC bought a new stake in shares of Roth Ch Acquisition V during the fourth quarter valued at approximately $956,000. Clear Street LLC bought a new stake in Roth Ch Acquisition V during the first quarter valued at about $84,000. Saba Capital Management L.P. bought a new position in Roth Ch Acquisition V during the fourth quarter valued at approximately $9,389,000. K2 Principal Fund L.P. bought a new position in Roth Ch Acquisition V in the fourth quarter worth approximately $3,542,000. Finally, Beryl Capital Management LLC acquired a new stake in shares of Roth Ch Acquisition V in the 4th quarter worth $4,540,000.
Roth Ch Acquisition V Company Profile
(Get Rating)Roth Ch Acquisition V Co does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. It intends to identify business opportunities in the field of business services, consumer, healthcare, technology, wellness, and sustainability sectors.
Featured Stories
- Get a free copy of the StockNews.com research report on Roth Ch Acquisition V (ROCLU)
- 3 Banks Worth Considering For Q4
- Is There a Cure for What is Ailing Teladoc Stock?
- No One Told These 3 Stocks It's a Down Week
- Why Medical Products Maker Repligen May Be A Potential Buy
- At 10%, Is Arbor Realty Trust Dividend Worth It?
Receive News & Ratings for Roth Ch Acquisition V Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roth Ch Acquisition V and related companies with MarketBeat.com's FREE daily email newsletter.